![Kristleifur Kristjansson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kristleifur Kristjansson
Nessuna posizione attualmente
Storia della carriera di Kristleifur Kristjansson
Precedenti posizioni note di Kristleifur Kristjansson
Società | Posizione | Inizio | Fine |
---|---|---|---|
EMBLA MEDICAL HF. | Direttore Tecnico/Scientifico/R&S | 01/01/2012 | 01/07/2022 |
deCODE genetics, Inc.
![]() deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Fondatore | 01/01/1995 | 01/01/2012 |
Corporate Officer/Principal | 01/01/1995 | 01/01/2012 | |
Skraeda ehf | Fondatore | - | - |
Formazione di Kristleifur Kristjansson
University of Iceland | Doctorate Degree |
Statistiche
Distribuzione geografica
Islanda | 5 |
Posizioni
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
EMBLA MEDICAL HF. | Health Technology |
Aziende private | 2 |
---|---|
deCODE genetics, Inc.
![]() deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
Skraeda ehf |